With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.246047-72-3,(1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium,as a common compound, the synthetic route is as follows.
To a solution of 1-isopropoxy-4-(perfluorodecyl)-2-vinylbenzene (35.5mg, 0.052mmol) in dry CH2Cl2 (4 mL) was added Grubbs 2nd generation (48.75 mg, 0.057 mmol) and CuCl (I) (8.2 mg, 0.083 mmol) under N2 at 35C and stirred for 3 h. The reaction mixture was concentrated in vacuo, and the residue was purified by column chromatography on silica gel (hexane / CH2Cl2 = 1 / 1) to give 1a (39.5mg, 65%).
As the paragraph descriping shows that 246047-72-3 is playing an increasingly important role.
Reference£º
Article; Kobayashi, Yuki; Inukai, Sae; Kondo, Natsuki; Watanabe, Tomoko; Sugiyama, Yuya; Hamamoto, Hiromi; Shioiri, Takayuki; Matsugi, Masato; Tetrahedron Letters; vol. 56; 11; (2015); p. 1363 – 1366;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI